Evidence map›Paper›PMID 41891720›Full record

ArticleAntimicrobial agents and chemotherapy2026

Prevalence and genetics of cefepime resistance among the AmpC-producing organisms

Sarah M Schrader, Zachary Pearson, Samantha Taffner, Sanjat Kanjilal, Nicole D Pecora

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarah M SchraderDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-4141-531X
Zachary PearsonDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Samantha TaffnerMass General Brigham, Boston, Massachusetts, USA.
Sanjat KanjilalDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.ORCID 0000-0002-1221-5725
Nicole D PecoraDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-5633-8746

Funding

Brigham and Women's Hospital Department of Pathology Internal funds
6 · The paper itself

Abstract

Cefepime is generally recommended for treatment of clinically significant AmpC producers, including

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCefepimeCitrobacter freundiiEnterobacter aerogenesEnterobacter cloacaeEnterobacteriaceae InfectionsHumansMicrobial Sensitivity TestsPrevalenceThird Generation CephalosporinsAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCefepimeThird Generation CephalosporinsAmpCBCID2cefepimeCitrobacter freundiiEnterobacter cloacaeESBLKlebsiella aerogenesmolecular diagnostics

Identifiers

PMID41891720
PMCPMC13148017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.